Disease & disorder

Prader-Willi syndrome

MONDO:0008300

Prader-Willi syndrome is a rare genetic disorder characterized by hypothalamic-pituitary abnormalities with severe hypotonia during the neonatal period and first two years of life and the onset of hyperphagia with a risk of morbid obesity during infancy and adulthood, learning difficulties and behavioral problems or severe psychiatric problems.

Clinical trials126
Recruiting14
Drug concepts studied12
Synonyms7

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…

Clinical trials

40 shown
Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion DysregulationNCT07607730 · 2027-01-01
RECRUITING
A Study of CSTI-500 in Patients With Prader-Willi SyndromeNCT07348601 · 2026-05-01
RECRUITING
Tirzepatide in PWS, HO and GNSONCT06901245 · 2025-05-01
RECRUITING
Autistic Symptomatology and Sensory Profile in Children With Prader-Willi SyndromeNCT06877715 · 2025-04-07
RECRUITING
Physical Activity and Community EmPOWERment ProjectNCT06740162 · 2025-01-10
RECRUITING
Institutional Registry of Rare DiseasesNCT06573723 · 2024-07-01
RECRUITING
A Study of Pitolisant in Patients With Prader-Willi SyndromeNCT06366464 · 2024-05-28
RECRUITING
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway ImpairmentNCT06239116 · 2024-03-05
RECRUITING
Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi SyndromeNCT06720571 · 2023-11-22
RECRUITING
Cerebellar TMS and Satiety in Prader-Willi SyndromeNCT05938543 · 2023-09-01
RECRUITING
The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and ProbioticsNCT05791604 · 2023-04-01
RECRUITING
GROWing Up With Rare GENEtic SyndromesNCT04463316 · 2018-10-01
RECRUITING
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)NCT05945576 · 2017-03-10
RECRUITING
Register of Patients With Prader-Willi SyndromeNCT02829684 · 2009-03-01
RECRUITING
A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.NCT07266324 · 2026-01-01
NOT_YET_RECRUITING
Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeNCT07450664 · 2025-11-26
ENROLLING_BY_INVITATION
A Study of Pitolisant in Participants With Prader-Willi SyndromeNCT07219485 · 2025-08-20
ENROLLING_BY_INVITATION
Brain Olfactory Pathways in Prader-Willi SyndromeNCT07006207 · 2025-06-23
NOT_YET_RECRUITING
A Study of Setmelanotide in Patients With Prader-Willi SyndromeNCT06772597 · 2025-03-04
ACTIVE_NOT_RECRUITING
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialNCT06828861 · 2024-12-20
TERMINATED
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialNCT07197034 · 2024-07-23
TERMINATED
Adolescent Projections During Transition in Prader-Willi SyndromeNCT06279052 · 2024-03-01
UNKNOWN
Respiratory Restriction in Prader-Willi SyndromeNCT06851351 · 2024-01-16
COMPLETED
A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWSNCT06144645 · 2024-01-08
ACTIVE_NOT_RECRUITING
Impact of Bright Light Therapy on Prader-Willi SyndromeNCT05939453 · 2023-10-01
ACTIVE_NOT_RECRUITING
An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)NCT05879614 · 2023-09-01
WITHDRAWN
Mitochondrial Complex I Dysfunction in PWSNCT03831425 · 2023-06-01
WITHDRAWN
Evaluation of the Psychological Profile of Adult Patients With Prader-Willi SyndromeNCT06295315 · 2023-04-21
COMPLETED
Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi SyndromeNCT05783791 · 2023-04-20
COMPLETED
Growth Hormone Study in Adults With Prader-Willi SyndromeNCT04484051 · 2023-03-24
UNKNOWN
Open-Label Extension Study of DCCR in Patients With Prader-Willi SyndromeNCT05701774 · 2023-01-31
ACTIVE_NOT_RECRUITING
Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi SyndromeNCT05541003 · 2023-01-06
COMPLETED
A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi SyndromeNCT05387798 · 2023-01-01
WITHDRAWN
A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi SyndromeNCT05504395 · 2022-11-14
COMPLETED
Ultrasound to Assess Sarcopenia in Prader Willi SyndromeNCT06448871 · 2022-10-17
COMPLETED
Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi SyndromeNCT05322096 · 2022-09-22
COMPLETED
A Study of Oral ARD-101 in Patients With Prader-Willi SyndromeNCT05153434 · 2022-05-27
COMPLETED
Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS)NCT05778032 · 2022-05-25
ACTIVE_NOT_RECRUITING
Characterization of Serum Proteome in Subjects With Prader Willi Syndrome (PROTEOMARKER)NCT05761184 · 2022-04-28
COMPLETED
A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi SyndromeNCT05098509 · 2022-04-13
TERMINATED

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.